ConvaTec : 2019 Annual Report & Accounts and Notice of AGM
March 16, 2020 at 11:43 am EDT
Share
Regulatory Story
Go to market news section
ConvaTec Group PLC - CTEC
2019 Annual Report & Accounts and Notice of AGM
Released 15:40 16-Mar-2020
RNS Number : 3304G
ConvaTec Group PLC
16 March 2020
2019 Annual Report & Accounts and
Notice of Annual General Meeting
READING, UNITED KINGDOM (16 March 2020)- ConvaTec Group Plc ('ConvaTec' or the 'Group'), a global medical products and technologies company, today announces that the following documents are now available on its website atwww.convatecgroup.com.
- 2019 Annual Report & Accounts
- Notice of 2020 Annual General Meeting
In compliance with Listing Rule 9.6.1, copies of the Annual Report and Notice of AGM have also been submitted to the National Storage Mechanism and will be available for inspection atwww.morningstar.co.uk/uk/NSM.
Printed copies of these documents will be sent to shareholders who have requested hard copies in due course.
Enquiries
Analysts and Investors
Mark Reynolds, Director Investor Relations, ConvaTec +44 (0)7551 036 625
ir@convatec.com
Media
Buchanan: Charles Ryland / Chris Lane / Vicky Haynes +44 (0)207 466 5000
ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92
About ConvaTec
ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion care. ConvaTec's products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visitwww.convatecgroup.comwhere a copy of this announcement can also be found.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.
2019 Annual Report & Accounts and Notice of AGM - RNS
Attachments
Original document
Permalink
Disclaimer
ConvaTec Group plc published this content on 16 March 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 16 March 2020 15:42:04 UTC
ConvaTec Group Plc specializes in the development, manufacturing and marketing of medical devices and products for ostomy care, wound care, incontinence and critical care. The group also offers perfusion devices. Net sales break down by area of activity as follows:
- wound care (29.9%): antimicrobial dressings, occlusive dressings, compression bandages, etc.;
- incontinence and critical care (26.4%);
- ostomy care (25.2%): skin barriers, one-piece bags, 2-piece appliance bags, urostomy bags, etc.;
- infusion (18.5%).
At the end of 2022, the group operated 9 production sites worldwide.
Net sales are distributed geographically as follows: Europe/Middle East/Africa (33.2%), Americas (52.6%) and Asia/Pacific (14.2%).
CONVATEC GROUP PLC 
